Treatment for cancer-related fatigue: An update

Expert Review of Anticancer Therapy

Volumn 3, Issue 1, 2003, Pages 99-106

  Manzullo, Ellen ^a   Liu, Wenli ^a   Escalante, Carmen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antidepressants; Cancer related fatigue; Erythropoietin alfa; Exercise; Methylphenidate; Modafinil; Patient education

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; DEXAMETHASONE; METHYLPHENIDATE; MODAFINIL; NORTRIPTYLINE; PAROXETINE; RECOMBINANT ERYTHROPOIETIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID;

ANEMIA; ANOREXIA; CANCER PATIENT; CANCER RELATED FATIGUE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FATIGUE; HUMAN; HYPERTENSION; INSOMNIA; KINESIOTHERAPY; NERVOUSNESS; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PATIENT EDUCATION; REVIEW; SIDE EFFECT; SLEEP; SYMPTOM; TACHYCARDIA;

EID: 0037319154     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.3.1.99     Document Type: Review

References (57)

1. Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. Oncology (Huntingt) 12(11A), 369-377 (1998).
2. Glaus A, Crow R, Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 4(2), 82-96 (1996).
3. Mock V, Dow KH, Meares CJ et al. Effects of exercise on fatigue, physical functioning and emotional distress during radiation therapy for breast cancer. Oncol. Nurs. Forum 24(6), 991-1000 (1997).
4. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit study group. J. Clin. Oncol. 16(10), 3412-3425 (1998).
5. Richardson A. Fatigue in cancer patients: a review of the literature. Eur. J. Cancer Care (Engl) 4(1), 20-32 (1995).
6. Love RR, Leventhal H, Easterling DV, Nerenz DR. Side effects and emotional distress during cancer chemotherapy. Cancer 63(3), 604-612 (1989).
7. Smets EM, Garssen B, Schuster-Uitterhoeve AL, de Haes JC. Fatigue in cancer patients. Br. J. Cancer 68(2), 220-224 (1993).
8. Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjoden PO. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur. J. Cancer 27(9), 1075-1081 (1991).
9. Devlen J, Maguire P, Phillips P, Crowther D. Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study. Br. Med. J. 295(6604), 955-957 (1987).
10. Mock V, Atkinson A, Barsevick A et al. NCCN practice guidelines for cancer-related fatigue. Nat. Comp. Cancer Net. 14(11A), 151-161 (2000).
11. Johnson JE. Self-regulation theory and coping with physical illness. Res. Nurs. Health 22(6), 435-448 (1999).
12. Richardson A, Ream E, Wilson-Barnett J. Fatigue in patients receiving chemotherapy: patterns of change. Cancer Nurs. 21(1), 17-30 (1998).
13. Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch. Gen. Psychiatry 38(5), 527-533 (1981).
14. Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D. A structured psychiatric intervention for cancer patients I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47(8),720--725 (1990).
15. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tcheckmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit study group. J. Clin. Oncol. 15(3), 1218-1234 (1997).
16. Gabrilove JL, Cleeland CS, Livingston RB et al. Once-weekly dosing of epoetin alfa is similar to three-times-weekly dosing in increasing hemoglobin and quality of life. Proc. Am. Soc. Clin. Oncol. 574A (1999).
17. Crawford J, Cella D, Cleeland CS et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 95(4), 888-895 (1999).
18. Greenleaf JE, Kozlowski S. Physiological consequences of reduced physical activity during bed rest. Exer. Sport Sci. Rev. 10, 84-119 (1982).
19. Germain P, Guell A, Marini JF. Muscle strength during bedrest with and without muscle exercise as a countermeasure. Eur. J. Appl. Physiol. Occupat. Physiol. 71(4), 342-348 (1995).
20. Levine BD, Zuckerman JH, Pawelczyk JA. Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance. Circulation 96(2), 517-525 (1997).
21. Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D. Psychosocial problems among survivors of Hodgkin's disease. J. Clin. Oncol. 4(5), 805-814 (1986).
22. Dimeo F, Stieglitz, RD, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J. Correlation between physical performance and fatigue in cancer patients. Ann. Oncol. 8(12), 1251-1255 (1997).
23. Winningham ML. Effects of a bicycle ergometry program on functional capacity and feelings of control in women with breast cancer. Ohio State University, Colombus, OH, 146 leaves. (1983).
24. Winningham ML, MacVicar MG, Bondoc M, Anderson JI, Minton JP. Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy. Oncol. Nurs. Forum 16(5), 683-689 (1989).
25. Mock V, Cameron L, Tompkins C et al. Every step counts: a walking exercise program for persons living with cancer. Johns Hopkins University, BA, USA (1997).
26. MacVicar MG, Winningham ML, Nickel JL. Promoting the functional capacity of cancer patients. Cancer Bulletin 38, 235-239 (1986).
27. Mock V, Burke MB, Sheehan P et al. A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy. Oncol. Nurs. Forum 21(5), 899-907; discussion 908 (1994).
28. Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 85(10), 2273-2277 (1999).
29. Schwartz AL. Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract. 8(1), 16-24 (2000).
30. Dimeo F, Rumberger BG, Keul J. Aerobic exercise as therapy for cancer fatigue. Med. Sci Sports Exerc. 30(4), 475-478 (1998).
31. Schwartz AL. Patterns of exercise and fatigue in physically active cancer survivors. Oncol. Nurs. Forum 25(3), 485-491 (1998).
32. Mock V, Ropka ME, Rhodes VA et al. Establishing mechanisms to conduct multi-institutional research - fatigue in patients with cancer: an exercise intervention. Oncol. Nurs. Forum 25(8), 1391-1397 (1998).
33. Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul J. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 79(9), 1717-1722 (1997).
34. Winningham ML, Burke C. Exercise for cancer patients: guidelines and precautions. Phys. Sportsmed. 14, 125-131 (1986).
35. Smets EM, Garssen B, Cull A, de Haes JC. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br. J. Cancer 73(2), 241-245 (1996).
36. Berger, AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol. Nurs. Forum 25(1), 51-62 (1998).
37. Hu DS, Silberfarb PM. Management of sleep problems in cancer patients. Oncology (Huntingt) 5(9), 23-27; discussion 28 (1991).
38. Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur. J. Cancer Care 10(4), 245-255 (2001).
39. Cimprich B. Attentional fatigue following breast cancer surgery. Res. Nurs. Health 15(3), 199-207 (1992).
40. Cimprich B. Development of an intervention to restore attention in cancer patients. Cancer Nurs. 16(2), 83-92 (1993).
41. Sarhill N, Nelson KA, Homsi J, LeGrand S, Davis MP. Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. Am. J. Hosp. Palliative Care 8(3), 187-192 (2001).
42. Faraj BA, Israili ZH, Perel JM et al. Metabolism and disposition of methylphenidate-14c: studies in man and animals. J. Pharmacol. Exp. Ther. 191(3), 535-547 (1974).
43. Wargin W, Patrick K, Kilts C et al. Pharmacokinetics for methylphenidate in man, rat and monkey. J. Pharmacol. Exp. Ther. 226, 382-386 (1983).
44. Rammohan KW, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and saftey of modafinil (provigil) for the treatment of fatigue in multiple sclerosis: a two centre Phase II study. J. Neurol. Neurosurg. Psychiatry 72, 179-183 (2002).
45. Derogatis LR, Morrow GR, Fetting J et al. The prevalence of psychiatric disorders among cancer patients. JAMA 249(6), 751-757 (1983).
46. Workman EA, Short DD. Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis. J. Clin. Psychiatry 54(1), 5-12 (1993).
47. Moertel CG, Reitemeier RJ, Hahn RG. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 33(6), 1607-1609 (1974).
48. Bruera E, Cadaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat. Rep. 69(7-8), 1708-1713 (1985).
49. Escalante CP, Grover T, Johnson BA et al. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer 92 (Suppl. 6) 1708-1713 (2001).
50. Mendoza TR, Wang XS, Cleeland CS et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5), 1186-4196 (1999).
51. Cleeland CS. Measurement of pain by subjective report. In: Advances in Pain Research and Therapy. Issues in Pain Measurement. Chapman CR, Loeser JD (Eds). Raven Press, NY, USA, 391-403 (1989).
52. Cleeland CS, Gonin R, Hatfield AK et al. Pain and its treatment in out-patients with metastatic cancer. N. Engl. J. Med. 330(9), 592-596 (1994).
53. Ottery, FD. Definition of standardized nutritional assessment and interventional pathways in oncology Nutrition 12 (Suppl. 1), S15-19 (1996).
54. Beck A, Steer R, Brown G. Manual for Beck Depression Inventory-II. Psychological Corp., San Antonio, TX, USA (1996).
55. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity Med. Care 34(3), 220-233 (1996).
56. Cleeland CS, Mendoza TR, Wang XS et al. Assessing symptom distress in cancer patients: The MD Anderson symptom inventory. Cancer 89(7), 1634-1646 (2000).
57. Gutstein HB. The biologic basis of fatigue. Cancer 92 (Suppl. 6), 1678-1683 (2001).